Premium
High activity iodine 125 endocurietherapy for recurrent skull base tumors
Author(s) -
Kumar P. Pradeep,
Good Roger R.,
Leibrock Lyal G.,
Mawk John R.,
Yonkers Anthony J.,
Ogren Frederic P.
Publication year - 1988
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19880415)61:8<1518::aid-cncr2820610807>3.0.co;2-d
Subject(s) - medicine , skull , cavernous sinus , chordoma , radiation therapy , hemangiopericytoma , meningioma , nasopharyngeal carcinoma , surgery , radiology
Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation‐induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high‐activity 125 iodine (I‐125) permanent implantation.